論文・技術情報追加のお知らせ

①Clinical Presentation and Outcomes of Myocarditis Post mRNA Vaccination: A Meta-Analysis and Systematic Review.

mRNAワクチン接種後の心筋炎の臨床症状と転帰

対象DB：VAERS

②Hepatotoxicity-Related Adverse Effects of Proton Pump Inhibitors: A Cross-Sectional Study of Signal Mining and Analysis of the FDA Adverse Event Report System Database.

プロトンポンプ阻害剤における肝毒性に関連した有害事象報告シグナルマイニング研究

対象DB：FAERS

③Ibrutinib-related skin cancer: A pharmacovigilance study from the Food and Drug Administration Adverse Event Reporting System.

イブルチニブに関連する皮膚がんのファーマコビジランス研究

対象DB：FAERS

④Postmarketing safety of anaplastic lymphoma kinase (ALK) inhibitors: an analysis of the FDA Adverse Event Reporting System (FAERS).

未分化リンパ腫キナーゼ（ALK）遺伝子変異阻害剤の市販後安全性調査研究

対象DB：FAERS

⑤Anaphylaxis rates associated with COVID-19 vaccines are comparable to those of other vaccines.

COVID-19ワクチンに関連するアナフィラキシー発生率調査研究

対象DB：EudraVigilance,VAERS

⑥Pharmacovigilance of Sodium-Glucose Cotransporter-2 Inhibitors for Genital Fungal Infections and Urinary Tract Infections: A Review of the Food and Drug Administration Adverse Event Reporting System Database.

SGLT2阻害剤投与患者における尿路感染症、性器真菌感染症の有病率評価研究

対象DB：FAERS

⑦Safety of Inulin and Sinistrin: Combining Several Sources for Pharmacovigilance Purposes.

イヌリンとシニストリンのファーマコビジランス研究

対象DB：FPVD,VigiBase

⑧Features of inflammatory heart reactions following mRNA COVID-19 vaccination at a global level.

mRNA COVID-19ワクチン接種後の心筋炎、心膜炎の特徴調査研究

対象DB：VigiBase